Stem Cell Research (Jun 2024)

Generation of a human iPSC line from a Parkinson’s disease patient with a novel CHCHD2 mutation (p.R145Q)

  • Xiaona Chen,
  • Jing Sun,
  • Tian Wang,
  • Qingyuan Tang,
  • Lu Su,
  • Yimin Sun,
  • Liang Chen,
  • Hyemyung Seo,
  • Tianlin Cheng,
  • Jian Wang,
  • Bin Song

Journal volume & issue
Vol. 77
p. 103419

Abstract

Read online

Mutations in CHCHD2 have been reported to be associated with familial Parkinson’s disease (PD). We generated a human induced pluripotent stem cell (hiPSC) line by reprogramming dermal fibroblasts from a PD patient harboring a novel CHCHD2 mutation (c.434G > A, p.R145Q). This line exhibited human embryonic stem cell (hESC)-like clonal morphology, expression of undifferentiated stem cell markers, a normal karyotype and trilineage differentiation capacity and thus the potential to serve as a model for further investigating the underlying molecular mechanisms of CHCHD2 function in PD.